Tomoyo Hara

发表

CELL BIOLOGY AND SIGNALING

V. P. Collins, Michael A. Koldobskiy, R. Spang, 2010 .

Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

M. Matsuhisa, A. Kuroda, S. Yoshida, 2022, Journal of atherosclerosis and thrombosis.

Blocking of the interaction between Wnt proteins and their co-receptors contributes to the anti-tumor effects of adenovirus-mediated DKK3 in glioblastoma.

H. Mure, T. Kageji, S. Nagahiro, 2015, Cancer letters.

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2

I. Endo, Toshio Matsumoto, K. Tanimoto, 2023, Antioxidants.

TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression

I. Endo, H. Sakaue, Toshio Matsumoto, 2022, Clinical & translational immunology.

Mechanical unloading aggravates bone destruction and tumor expansion in myeloma

I. Endo, K. Tanimoto, M. Abe, 2021, Haematologica.

Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes.

M. Matsuhisa, A. Kuroda, S. Yoshida, 2023, Heliyon.

Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes

M. Matsuhisa, A. Kuroda, S. Yoshida, 2021, Journal of diabetes investigation.

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors

I. Endo, M. Abe, E. Tanaka, 2023, International Journal of Hematology.

Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma

Kiyoe Kurahashi, I. Endo, H. Hasegawa, 2023, EJHaem.

Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes

M. Matsuhisa, H. Mori, A. Kuroda, 2023, Metabolites.

PS-P07-5: PHARMACEUTICAL INFLUENCES ON IN-HOSPITAL DEATH IN PATIENTS WITH AND THOSE WITHOUT DIABETES AT A JAPANESE COMMUNITY GENERAL HOSPITAL

S. Yoshida, Kiyoe Kurahashi, I. Endo, 2023, Vascular pharmacology.

Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study

M. Matsuhisa, T. Yuasa, Tomoyo Hara, 2023, Diabetes therapy : research, treatment and education of diabetes and related disorders.

Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.

Kiyoe Kurahashi, I. Endo, M. Hiasa, 2024, International journal of hematology.

Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes

M. Matsuhisa, A. Kuroda, Kiyoe Kurahashi, 2024, Biomedicines.

Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011–2020) in Individuals with and without Diabetes at a Japanese Community General Hospital

M. Matsuhisa, A. Kuroda, Kiyoe Kurahashi, 2024, Journal of clinical medicine.